Prelude Therapeutics
PRLD
#8532
Rank
HK$2.02 B
Marketcap
HK$25.32
Share price
-0.77%
Change (1 day)
94.81%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2026 (TTM): -HK$7.36

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$7.37. In 2025 the company made an earnings per share (EPS) of -HK$10.11 an increase over its 2024 EPS that were of -HK$13.17.

EPS history for Prelude Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$7.36-27.23%
2025-HK$10.11-23.21%
2024-HK$13.17-16.83%
2023-HK$15.83-17.21%
2022-HK$19.130.41%
2021-HK$19.05-46.71%
2020-HK$35.74435.92%
2019-HK$6.6786.09%
2018-HK$3.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 43.62%๐Ÿ‡บ๐Ÿ‡ธ USA